Currently, the FDA relies on manufacturers to report supply levels, which raises concerns about transparency and whether financial incentives might influence these reports
In fact, some trials showed lower rates of depressive symptoms in GLP-1 groups, likely due to improved quality of life and reduced inflammation
Taking tirzepatide with food, staying hydrated, and eating smaller, protein-rich meals helps buffer these symptoms
typically resolves with dose adjustment or taking with food *Zinc depletion - high-dose, long-term glutathione supplementation may reduce zinc absorption
Inflammation-sleep interface in brain disease: TNF, insulin, orexin
Patients often report an improved quality of life and greater ease in performing daily activities